Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine
Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
To examine the relative potency, onset of action and duration of action of fexofenadine HCl
180 mg (ALLEGRA) and desloratadine 5 mg (CLARINEX) as compared to placebo on skin wheals and
flares induced by histamine.